Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Narrative)

v3.21.1
Commitments and Contingencies (Details Narrative)
12 Months Ended
Aug. 15, 2020
USD ($)
Dec. 13, 2019
USD ($)
$ / shares
shares
Dec. 13, 2019
EUR (€)
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2020
EUR (€)
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Total Long-Term Debt       $ 3,448,204      
Net Operating Losses       $ 24,000,000     $ 17,300,000
Operating Lease Right of Use Obligations [Member]              
Weighted average discount rate       2.87%   2.87%  
Weighted average remaining lease term       39 months 39 months    
Operating lease right-of-use assets and liabilities       $ 326,085     $ 331,452
Payment of lease liabilities       230,627      
Operating lease expense       231,343      
Short term lease costs       30,117      
Collaborative Agreement [Member]              
Total long-term debt       0      
Repayment of long-term loan amount       160,000      
Managing Director's Agreement [Member]              
Total long-term debt       $ 176,085      
Transaction agreement description       In connection with the transaction agreement, the Company also entered into a 2-year Managing Director’s agreement with the founder of Octamer to continue to manage Volition Germany for a payment of €288,000 Euros payable in equal monthly installments over such 2-year period and a royalty agreement with the founder providing for the payment of royalties in the amount of 6% of net sales of Volition Germany’s nucleosomes as reagents to pharmaceutical companies for use in the development, manufacture and screening of molecules for use as therapeutic drugs for a period of 5 years post-closing. In connection with the transaction agreement, the Company also entered into a 2-year Managing Director’s agreement with the founder of Octamer to continue to manage Volition Germany for a payment of €288,000 Euros payable in equal monthly installments over such 2-year period and a royalty agreement with the founder providing for the payment of royalties in the amount of 6% of net sales of Volition Germany’s nucleosomes as reagents to pharmaceutical companies for use in the development, manufacture and screening of molecules for use as therapeutic drugs for a period of 5 years post-closing.    
Holdback liabilities       $ 52,581      
Royalty payment       134,217      
Amount payable       $ 239      
Royality       6.00% 6.00%    
Stock based compensation expenses       $ 753,000      
November 4, 2020 [Member] | Novis Animal Solutions LLC [Member]              
Compensation payable       $ 19,000      
October 25, 2019 [Member] | TAMU [Member]              
Non-controlling interest       7.50% 7.50%    
Equity interest       12.50% 12.50%    
Additional interest       5.00% 5.00%    
November 3, 2020 [Member] | Diagnostic Oncology CRO, LLC [Member]              
Transaction agreement description       The initial projects contemplated by the agreement relating to Non-Hodgkin’s Lymphoma obligate the Company to pay in aggregate of up to $2.9 million over a period of 22 months. Such payment obligations are on a project-by-project basis as deliverables are executed and subject to certain terms and conditions. Additionally, the Company may terminate the agreement or any project with or without cause upon at least 30 days’ prior written notice The initial projects contemplated by the agreement relating to Non-Hodgkin’s Lymphoma obligate the Company to pay in aggregate of up to $2.9 million over a period of 22 months. Such payment obligations are on a project-by-project basis as deliverables are executed and subject to certain terms and conditions. Additionally, the Company may terminate the agreement or any project with or without cause upon at least 30 days’ prior written notice    
November 10, 2020 [Member] | Singapore Volition and PB Commodities Pte Ltd [Member]              
Monthly Fees       $ 35,650      
January 10, 2020 [Member]              
Common stock, restricted shares issued in exchange of purchased outstanding shares, value   $ 333,969          
Restricted shares issued | shares   73,263 73,263        
Common stock, restricted shares issued in exchange of purchased outstanding shares, shares | shares   73,263 73,263        
Weighted trading price per share | $ / shares   $ 4.56          
Repayment of debt | €     € 350,000        
Common stock adjusted amount   $ 357,000          
Holdback period       9 months 9 months    
Holdback liabilities       $ 55,404      
Net liabilities   $ 6,535          
On September 16, 2020 [Member] | Bioinformatic Analytics Of Cell Free DNA [Member]              
Total long-term debt       44,738      
Repayment of long-term loan amount | €         € 54,879    
In 2019 [Member] | Taxes A&M University [Member]              
Repayment of long-term loan amount       $ 400,000      
Loan agreement term       5 years 5 years    
Collaborative obligations amount due       $ 329,986      
In 2018 [Member] | Long-term Debt [Member] | Namur Innovation and Growth [Member]              
Fixed interest rate on lease       4.00%   4.00%  
In 2018 [Member] | Loan Agreement [Member] | Long-term Debt [Member] | Namur Innovation and Growth [Member]              
Total long-term debt       $ 272,524      
Repayment of long-term loan amount | €         € 500,000    
Loan agreement term       4 years 4 years    
Maturity date       Jun. 30, 2022 Jun. 30, 2022    
In 2015 [Member] | Finance Lease Obligations [Member] | Automated Liquid Handling Robots [Member]              
Maturity date       May 31, 2020 May 31, 2020    
Amount payable       $ 0      
Purchase price for the property | €           € 550,454  
In 2018 [Member] | Finance Lease Obligations [Member] | BNP Paribas leasing solutions [Member]              
Maturity date       Jan. 31, 2022 Jan. 31, 2022    
Amount payable       $ 11,688      
Purchase price for the property | €           € 25,000  
Implicit interest       1.35%   1.35%  
Leased equipment amortized term       5 years 5 years    
In 2016 [Member] | Finance Lease Obligations [Member] | ING Asset Finance Belgium S.A. [Member]              
Maturity date       May 31, 2031 May 31, 2031    
Amount payable       $ 650,209      
Purchase price for the property | €           € 1,120,000  
Implicit interest       2.62%   2.62%  
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member]              
Collaborative obligations amount due       $ 96,000      
Research collaboration agreement description       The Company entered into a research collaboration agreement with the University of Taiwan to collect a total of 1,200 samples for a 2-year period for a cost to the Company of up to $320,000 payable over such period The Company entered into a research collaboration agreement with the University of Taiwan to collect a total of 1,200 samples for a 2-year period for a cost to the Company of up to $320,000 payable over such period    
Namur [Member] | October 13, 2020 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       4.00%   4.00%  
Total long-term debt       $ 934,896      
Principal balance payable | €         € 764,547    
Repayment of long-term loan amount | €         € 830,000    
Loan agreement term       10 years 10 years    
Maturity date       Mar. 31, 2021 Mar. 31, 2021    
Belgian Volition [Member] | October 1, 2020 [Member] | Chief Executive Officer [Member]              
Description of agreement       i) €10,000 per month, and (ii) the equivalent of one-half of his salary for the 12-month non-competition period following termination of the agreement, subject to adjustments. i) €10,000 per month, and (ii) the equivalent of one-half of his salary for the 12-month non-competition period following termination of the agreement, subject to adjustments.    
Novis Animal Solutions LLC [Member]              
Monthly Fees $ 20,000            
sales commission 5.00%            
Potential Equity Interest 2.00%            
Namur Invest [Member] | In 2019 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       4.80%   4.80%  
Total long-term debt       $ 611,406      
Repayment of long-term loan amount | €         € 500,000    
Loan agreement term       4 years 4 years    
Maturity date       Sep. 30, 2024 Sep. 30, 2024    
Namur Invest [Member] | In 2017 [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       4.00%   4.00%  
Namur Invest [Member] | In 2017 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Total long-term debt       $ 64,863      
Repayment of long-term loan amount | €         € 350,000    
Loan agreement term       4 years 4 years    
Maturity date       Jun. 30, 2021 Jun. 30, 2021    
Namur Invest [Member] | In 2016 [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       4.85%   4.85%  
Namur Invest [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Total long-term debt       $ 269,400      
Repayment of long-term loan amount | €         € 440,000    
Loan agreement term       7 years 7 years    
Maturity date       Dec. 31, 2023 Dec. 31, 2023    
SOFINEX [Member] | In 2017 [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       4.50%   4.50%  
SOFINEX [Member] | In 2017 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Total long-term debt       $ 1,039,390      
Repayment of long-term loan amount | €         € 1,000,000    
Loan agreement term       7 years 7 years    
Maturity date       Sep. 30, 2024 Sep. 30, 2024    
ING [Member] | In 2016 [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       2.62%   2.62%  
ING [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Total long-term debt       $ 255,725      
Repayment of long-term loan amount | €         € 270,000    
Loan agreement term       15 years 15 years    
Maturity date       Dec. 31, 2031 Dec. 31, 2031    
Walloon Region Government [Member] | In 2018 [Member] | Colorectal Cancer Research Agreement [Member]              
Amount payable       $ 221,940      
Grant receivable | €           € 605,000  
Repayment of grants | €           181,500  
Terms of agreement description       It is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received It is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received    
Total grants repayable       $ 328,821      
Walloon Region Government [Member] | In 2010 [Member]              
Repayment of long-term loan amount | €         € 733,614    
Amount payable       $ 106,881      
Grant receivable | €           1,050,000  
Repayment of grants | €           314,406  
Terms of agreement description       It is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is twice the amount of funding received It is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is twice the amount of funding received    
University of Michigan [Member] | In 2017 [Member] | Clinical Study Research Agreement [Member]              
Collaborative obligations amount due       $ 0      
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount | €           3,000,000  
Munich University [Member] | In 2017 [Member] | Collaborative Research Agreement [Member]              
Collaborative obligations amount due       $ 0      
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount | €           360,000  
DKFZ [Member] | In 2016 [Member] | Research Co-operation Agreement [Member]              
Collaborative obligations amount due       $ 244,562      
Lease agreement expire period       5 years 5 years    
Collaborative obligations amount | €           400,000  
DKFZ [Member] | In 2015 [Member] | Research Sponsorship Agreement [Member]              
Collaborative obligations amount due       $ 0      
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount | €           € 338,984  
University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member]              
Collaborative obligations amount due       $ 892,500      
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount       $ 2,550,000